After a stent, a moderate statin plus ezetimibe protected as well with less diabetes
Pooling seven studies with 121,480 patients who had a coronary stent, a moderate-intensity statin plus ezetimibe was linked to a lower risk of new diabetes (RR 0.83) and similar heart events compared…